HIV-Tb Confections Among HIV Patients
NCT02964767 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219
Last updated 2017-10-04
Summary
A cross sectional study would be done for prevalence of HIV-Tb. co infection among patients of HIV enrolled at ART centre, Khagaria, India, during June' 2015 to May' 2016. A comparative study of CD4 (cluster of differentiation 4) T cell count among HIV-Tb. co infected patient and HIV patients would be taken in account.
Conditions
Sponsors & Collaborators
-
Singh, Ranjan Kumar, M.D.
lead INDIV
Principal Investigators
-
Ranjan K Singh, M.D. · Physician cum nodal officer, ART centre, Khagaria, India.
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2016-05-31
- Completion
- 2016-11-30
Countries
- India
Study Locations
More Related Trials
-
Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
NCT00341328 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
NCT00698334 ·Status: COMPLETED ·Phase: PHASE3
-
Preventive Therapy for Tuberculosis in HIV Infected Persons
NCT00351702 ·Status: COMPLETED ·Phase: PHASE3
-
Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
NCT06709157 ·Status: NOT_YET_RECRUITING
-
Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
NCT01875952 ·Status: UNKNOWN ·Phase: PHASE4
-
Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People
NCT00959088 ·Status: COMPLETED
-
Evaluation of Centralised TB Assay Solutions
NCT04147676 ·Status: COMPLETED
-
Innovation in Tuberculosis
NCT04002869 ·Status: UNKNOWN
-
TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
NCT00023361 ·Status: COMPLETED ·Phase: NA
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
NCT04930744 ·Status: COMPLETED ·Phase: PHASE2
-
Brief Bactericidal Activity of Anti-Tuberculosis Drugs
NCT02236078 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
NCT00402454 ·Status: COMPLETED ·Phase: PHASE4
-
Interferon Gamma for Drug Resistant Tuberculosis
NCT00001407 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
NCT00402610 ·Status: COMPLETED ·Phase: PHASE4
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
NCT00201123 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Absorption and Utilization During Tuberculosis and After Treatment
NCT02176772 ·Status: COMPLETED
-
Comparison Between Two Strategies for the Diagnosis of TB
NCT02961569 ·Status: COMPLETED ·Phase: NA
-
Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients
NCT05329415 ·Status: UNKNOWN
-
Pulmonary Tuberculosis Patients With Diabetes Mellitus
NCT02106039 ·Status: COMPLETED ·Phase: NA
-
First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b
NCT06050356 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Registry of Tuberculosis Cases in the CPCRA
NCT00000785 ·Status: COMPLETED
-
TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)
NCT00107887 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam
NCT00651066 ·Status: COMPLETED ·Phase: PHASE2